Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.

Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.

Splicing factor gene mutations are the most frequent mutations found in patients with the myeloid malignancy myelodysplastic syndrome (MDS), suggesting that spliceosomal dysfunction plays a major role in disease pathogenesis. The aberrantly spliced target genes and deregulated cellular pathways asso...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Pellagatti, A, Boultwood, J
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	Elsevier 2016

Eitemau Tebyg

Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches
gan: Armstrong, R, et al.
Cyhoeddwyd: (2017)

The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
gan: Boultwood, J, et al.
Cyhoeddwyd: (2014)

Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations
gan: Pellagatti, A, et al.
Cyhoeddwyd: (2017)

Gene expression profiling in the myelodysplastic syndromes.
gan: Pellagatti, A, et al.
Cyhoeddwyd: (2005)

Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations
gan: Johanna Flach, et al.
Cyhoeddwyd: (2020-09-01)

SF3B1 mutant myelodysplastic syndrome: Recent advances
gan: Pellagatti, A, et al.
Cyhoeddwyd: (2020)

Lack of splice factor and cohesin complex mutations in pediatric myelodysplastic syndrome
gan: Julia C. Obenauer, et al.
Cyhoeddwyd: (2016-12-01)

The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes.
gan: Yip, B, et al.
Cyhoeddwyd: (2017)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
gan: Boultwood, J, et al.
Cyhoeddwyd: (2009)

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GENE IN MYELODYSPLASTIC SYNDROMES - REPLY
gan: Boultwood, J, et al.
Cyhoeddwyd: (1991)

Gene expression profiling in 5q-syndrome and myelodysplastic syndromes.
gan: Pellagatti, A, et al.
Cyhoeddwyd: (2003)

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.
gan: Fernandez-Mercado, M, et al.
Cyhoeddwyd: (2013)

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression
gan: Fernandez-Mercado, M, et al.
Cyhoeddwyd: (2013)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 In Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
gan: Fernandez-Mercado, M, et al.
Cyhoeddwyd: (2010)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
gan: Fernandez-Mercado, M, et al.
Cyhoeddwyd: (2013)

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
gan: Boultwood, J, et al.
Cyhoeddwyd: (2010)

Clonality in the myelodysplastic syndromes.
gan: Boultwood, J, et al.
Cyhoeddwyd: (2001)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes
gan: Marta Fernandez-Mercado, et al.
Cyhoeddwyd: (2013-12-01)

The impact of spliceosome mutations in MDS
gan: Jacqueline Boultwood, et al.
Cyhoeddwyd: (2019-06-01)

A novel splicing mutation in the gene encoding the chromatin-associated factor ATRX associated with acquired hemoglobin H disease in myelodysplastic syndrome (ATMDS)
gan: Steensma, D, et al.
Cyhoeddwyd: (2004)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
gan: Pellagatti, A, et al.
Cyhoeddwyd: (2008)

Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1 mutant myelodysplastic syndromes
gan: Dolatshad, H, et al.
Cyhoeddwyd: (2016)

Discovering transcription and splicing networks in myelodysplastic syndromes.
gan: Hongyan Wang, et al.
Cyhoeddwyd: (2013-01-01)

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
gan: Bernard, E, et al.
Cyhoeddwyd: (2020)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
gan: Pellagatti, A, et al.
Cyhoeddwyd: (2009)

Molecular pathogenesis of the myelodysplastic syndromes
gan: Boultwood, J, et al.
Cyhoeddwyd: (1999)

High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation
gan: Liberante, F, et al.
Cyhoeddwyd: (2013)

High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation.
gan: Liberante, F, et al.
Cyhoeddwyd: (2013)

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
gan: Pellagatti, A, et al.
Cyhoeddwyd: (2010)

Mutations in PTPN11 are rare in adult myelodysplastic syndromes and acute myeloid leukemia.
gan: Watkins, F, et al.
Cyhoeddwyd: (2004)

COMPREHENSIVE ANALYSIS OF MUTATION STATUS, GENE EXPRESSION PROFILES, BLOOD AND BONE MARROW COUNTS AND OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
gan: Pellagatti, A, et al.
Cyhoeddwyd: (2014)

Gene expression profiling in patients with myelodysplastic syndromes, including patients with the del(5q)
gan: Boultwood, J
Cyhoeddwyd: (2009)

Telomere length in myelodysplastic syndromes.
gan: Boultwood, J, et al.
Cyhoeddwyd: (1995)

Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1
gan: Iva Trsova, et al.
Cyhoeddwyd: (2023-12-01)

Structure of the granulocyte macrophage colony-stimulating factor gene in patients with the myelodysplastic syndromes.
gan: Boultwood, J, et al.
Cyhoeddwyd: (1990)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
gan: Pellagatti, A, et al.
Cyhoeddwyd: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
gan: Pellagatti, A, et al.
Cyhoeddwyd: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
gan: Pellagatti, A, et al.
Cyhoeddwyd: (2010)

8 Gene expression profiling in patients with myelodysplastic syndromes, including patients with the del(5q)
gan: Boultwood, J
Cyhoeddwyd: (2009)

Neutrophil PRV-1 gene expression in myeloproliferative, myelodysplastic and reactive blood disorders
gan: Zhang, J, et al.
Cyhoeddwyd: (2004)